Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA accuses firm of selling unapproved drugs

This article was originally published in The Tan Sheet

Executive Summary

Under a consent decree with FDA, Risingsun Health and the Center for Complimentary and Alternative Health in Livingston, Mont., agree to hire an independent expert for pre-market review of product claims and to certify the claims are compliant. The decree, which also prohibits the firms from selling unapproved new drugs, was filed in the U.S. District Court for the District of Montana and resolves charges the firm sold ineffective products. Prior to signing the decree, Risingsun made and distributed unapproved new drugs, including Black Salve, Cancema and Can-Support, purported to treat cancer, asthma, anemia and epilepsy, FDA said Oct. 13

You may also be interested in...



Amgen To Buy Out Japan JV With Astellas

Full, planned acquisition of Tokyo-based operation will give US biotech giant a firmer foothold in key market and new platform for Otezla growth.

QUOTED. 23 January 2020. John Milad.

Quanta Dialysis is linking up with B. Braun Avitum UK to support patients with Quanta’s personal hemodialysis device in the home. See what Quanta CEO John Milad said about it here.

EU’s Cosmetic Microplastic Restriction Expected To Be ‘Very Wide-Ranging’ At Best

Cosmetics Europe’s Director-General John Chave discusses next steps in the European Union’s proposed drive to ban manufactured microplastic in all cosmetic products. Industry continues to fight for something more proportionate, but it’s up against powerful forces in today’s European theater.

Topics

UsernamePublicRestriction

Register

PS104624

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel